Drug shortage
Benztropine Mesylate Injection · Fresenius Kabi USA, LLC
FDA drug shortage · To Be Discontinued · updated Jan 27, 2026
Key facts
| Generic name | Benztropine Mesylate Injection |
|---|---|
| Company | Fresenius Kabi USA, LLC |
| Presentation | Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Neurology |
| Package NDCs | 63323-970-02 |
| First posted | Jan 27, 2026 |
| Last updated | Jan 27, 2026 |
| Discontinued | Jan 27, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: